Dyspnoea, obstruction, smoking and exacerbation (DOSE) index and mortality in COPD Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes Year: 2011
The body-mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index in Filipino patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 57s Year: 2005
Sex differences in mortality in patients with COPD Source: Eur Respir J 2009; 33: 528-535 Year: 2009
Minimal important difference of the transition dyspnoea index in a multinational clinical trial Source: Eur Respir J 2003; 21: 267-272 Year: 2003
The relationship between COPD assessment test (CAT) scores and severity of airflow obstruction in stable COPD patients Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases Year: 2012
Fatigue in COPD: association with functional status and hospitalisations Source: Eur Respir J 2013; 41: 565-570 Year: 2013
Respiratory symptoms, smoking history and airflow limitation: How should we define COPD? Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes Year: 2011
Interpreting thresholds for a clinically significant change in health status in asthma and COPD Source: Eur Respir J 2002; 19: 398-404 Year: 2002
Change in BODE index, exacerbation duration and hospitalisation in a cohort of COPD patients Source: Annual Congress 2008 - Prognosis in COPD Year: 2008
A new multidimensional model for predicting mortality in COPD: body mass index and FEV1 quotient/MRC dyspnoea score (SID) Source: Annual Congress 2006 - COPD – the challenges for primary care Year: 2006
An observational study of age-related smoking status in COPD patients stratified by severity of airflow obstruction Source: International Congress 2015 – Management of asthma and COPD in primary care Year: 2015
Baseline symptom scores and future risk of severe exacerbation: The SPARK study Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015
Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study Source: Annual Congress 2013 –COPD mechanisms Year: 2013
Body mass is related to smoking status and severity of airflow obstruction in COPD Source: Eur Respir J 2003; 22: Suppl. 45, 538s Year: 2003
Significance of quantitative radiological phenotypes of COPD on BODE index Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016
The availibility of copd assessment test (CAT) in determination of risk of early hospitalization in chronic obstructive pulmonary disease patients and its correlation with pulmonary function tests, dyspnea measurement scales and St George respiratory questionnaire Source: International Congress 2014 – COPD markers Year: 2014
Change in clinical COPD questionnaire (CCQ) symptoms domain score and FEV1 predict treatment failure during hospitalisation due to COPD exacerbations Source: Eur Respir J 2007; 30: Suppl. 51, 525s Year: 2007
Relationship between symptoms and airflow limitation in COPD: in stable disease and during exacerbations Source: Eur Respir J 2002; 20: Suppl. 38, 250s Year: 2002
Baseline self-reported comorbidity in COPD patients referred for pulmonary rehabilitation (PR) Source: Annual Congress 2006 - COPD comorbidity Year: 2006
Impact of chronic airflow obstruction in a working population Source: Eur Respir J 2008; 31: 1227-1233 Year: 2008